You have 9 free searches left this month | for more free features.

Obatoclax

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Follicular Trial in Hackensack (Obatoclax mesylate, Rituximab)

Completed
  • Lymphoma, Follicular
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
Jul 20, 2016

Mantle-Cell Lymphoma Trial in United States (Obatoclax mesylate, Bortezomib)

Completed
  • Mantle-Cell Lymphoma
  • Marietta, Georgia
  • +4 more
Jul 19, 2016

Lung Cancer Trial in United States (Obatoclax mesylate 250 ml, Docetaxel)

Completed
  • Lung Cancer
  • Scottsdale, Arizona
  • +6 more
Jul 19, 2016

Metastatic Melanoma Trial in Philadelphia (Obatoclax Mesylate, Temozolomide)

Terminated
  • Metastatic Melanoma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 20, 2016

Obatoclax Mesylate in Samples From Young Acute Myeloid Leukemia

Completed
  • Leukemia
  • gene expression analysis
  • +6 more
  • (no location specified)
May 17, 2016

Extensive-stage Small Cell Lung Cancer Trial in Worldwide (Obatoclax, Carboplatin/etoposide)

Completed
  • Extensive-stage Small Cell Lung Cancer
  • Huntsville, Alabama
  • +74 more
Jul 19, 2016

Adult Non-Hodgkin Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Duarte

Terminated
  • Adult Non-Hodgkin Lymphoma
  • +7 more
  • obatoclax mesylate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 3, 2015

Recurrent Small Cell Lung Cancer, Solid Tumor Trial in Baltimore, New York (obatoclax mesylate, topotecan HCl, laboratory

Completed
  • Recurrent Small Cell Lung Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • obatoclax mesylate
  • +2 more
  • Baltimore, Maryland
  • +1 more
Apr 14, 2015

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (obatoclax mesylate,

Terminated
  • Refractory Multiple Myeloma
  • +3 more
  • obatoclax mesylate
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 9, 2015

Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))

Completed
  • Hematological Malignancies
  • Obatoclax mesylate (GX15-070MS)
  • Washington, District of Columbia
  • +2 more
May 9, 2014

Chronic Lymphocytic Leukemia Trial in Canada, United States (GX15-070MS)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +4 more
May 9, 2014

B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +7 more
  • obatoclax mesylate
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 27, 2013

AML Trial in Canada, United States (Obatoclax)

Completed
  • AML
  • Obatoclax
  • Chicago, Illinois
  • +12 more
Aug 16, 2013

Myelofibrosis Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))

Completed
  • Myelofibrosis
  • Obatoclax mesylate (GX15-070MS)
  • Washington, District of Columbia
  • +6 more
Aug 16, 2013

MDS Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))

Completed
  • Myelodysplastic Syndromes
  • Obatoclax mesylate (GX15-070MS)
  • Stanford, California
  • +21 more
Aug 16, 2013

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus (bendamustine HCl, obatoclax

Withdrawn
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +6 more
  • bendamustine hydrochloride
  • +2 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jun 5, 2013

Extensive-stage Small Cell Lung Cancer Trial (Obatoclax Mesylate, Carboplatine and Etoposide, Carboplatin and Etoposide)

Withdrawn
  • Extensive-stage Small Cell Lung Cancer
  • Obatoclax Mesylate, Carboplatine and Etoposide
  • Carboplatin and Etoposide
  • (no location specified)
Aug 14, 2012

Hodgkin's Lymphoma Trial in Houston (Obatoclax mesylate (GX15-070MS))

Completed
  • Hodgkin's Lymphoma
  • Obatoclax mesylate (GX15-070MS)
  • Houston, Texas
    MD Anderson Cancer Center
Aug 3, 2012

Leukemia, Systemic Mastocytosis Trial in Houston (Obatoclax Mesylate)

Terminated
  • Leukemia
  • Systemic Mastocytosis
  • Obatoclax Mesylate
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 14, 2011